Deal or Case news
02.08.2022 5 min read
On 25 July 2022, NewAmsterdam Pharma and Frazier Lifesciences Acquisition Corporation announced that they have entered into a definitive business combination agreement that would result in NewAmsterdam Pharma Company N.V., a newly formed company.

NewAmsterdam Pharma, a late clinical-stage company focused on the research and development of transformative oral therapies for major cardiometabolic diseases, and Frazier Lifesciences Acquisition Corporation, a special purpose acquisition company sponsored by an affiliate of Frazier Healthcare Partners, announced that they have entered into a definitive business combination agreement that would result in NewAmsterdam Pharma Company N.V., a newly formed company, becoming a publicly listed company on Nasdaq.

With two de-SPAC transactions (NewAmsterdam Pharma and Next.e.GO) signed within the same week, NautaDutilh’s public M&A team underscores its leading position in this field and is off to a great start of H2 2022.
Partner Paul van der Bijl

"With two de-SPAC transactions (NewAmsterdam Pharma and Next.e.GO) signed within the same week, NautaDutilh’s public M&A team underscores its leading position in this field and is off to a great start of H2 2022. We are proud to have acted alongside our friends at Covington & Burling to get to this point.", says lead partner Paul van der Bijl.

Paul van der Bijl and Ruud Smits led the NautaDutilh team which consisted of Joppe Schoute, Daan Hagelstein, Marloes van der Laan, Thomas Castermans and Eline van Marle (Corporate), Nina Kielman (Tax), Liselotte Bekke, Maaike Lelifeld (IP), Arjan Koorevaar (Employment) and Terrence Dom and Tom de Smet (IT/Privacy).

Related articles

Cookie notification

This functionality uses third-party cookies. Change your cookie preferences to view this content or view more information.
These cookies ensure that the website works properly. These cookies cannot be disabled.
These cookies can be placed by third parties, such as YouTube or Vimeo.
By deactivating categories, it is possible that related functionalities within the website may no longer work properly. It is always possible to change your preferences at a later time. View more information.